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Purpose. Use of microperimetry (Mp-1), correlating with Humphrey perimetry (30-2 program), in patients affected by primary
open-angle glaucoma (POAG) with perimetric defects, in order to obtain an evaluation of the accuracy of the results obtained
by Mp-1.Materials and Methods. In this study 40 eyes of 25 patients affected by POAG with perimetric defects were included. All
patients underwentmicroperimetry test byNidekMp-1 (NAVIS software version 1.7.2, Nidek Technologies).Mean sensitivity values
expressed in decibel (dB) of all tested dots and mean values for each quadrant obtained by microperimetric test were correlated
with corresponding quadrants obtained by static perimetry analysis. Data were analyzed by Pearson’s correlation and Bland-Altman
analysis. Results. Interpolated data showed that mean sensitivity values in all spots tested by Mp-1 (11.98 dB, SD 4.31) may be
significantly correlated with mean total values obtained by Humphrey 30-2 perimetry (17.95, SD 4.32), with correlation coefficient
of 0.556. Conclusions. Topographic visualization of the perimetric alteration by microperimetry allows retesting areas with reduced
sensitivity which are topographically visualized and displayable on the ocular fundus examination, avoiding worsening of the
functional defect by better modulation of the antiglaucoma therapy and therefore it allows better monitoring of the pathologic
functional damage.
1. Introduction
Glaucoma is classically recognized as the main ocular con-
dition causing irreversible blindness occurring in 70 million
subjects worldwide. It consists in an ocular neuropathy pro-
gressing into an over loss of retinal ganglion cells (RGC) and
their axons which determines the crucial organic-functional
damage [1].
For the diagnosis of glaucoma, the detection of alteration
occurring at the optic nerve head level, abnormalities of the
retinal nerve fiber layer (RNFL), visual field loss, and the
presence of elevated intraocular pressure (IOP) is fundamen-
tal.
Currently, various assessment and functional tests are
used for the diagnosis of the glaucoma (assessment: namely,
scanning laser polarimetry, Heidelberg Retinal Tomography,
and optical coherence tomography. Functional test: com-
puterized automated perimetry: Humphrey, Octopus; color
vision study; contrast sensitivity study; light accommodation
study). Among functional tests, the automated (computer-
ized) perimetry is considered the gold standard for both
diagnosis and follow-up because of its elevated sensitivity
to detect perimetric abnormalities using full threshold test
or SITA-Standard with Humphrey perimeter evaluating a
sufficient dot density, distributed within “the 30∘ area.”
Nevertheless, the computerized automated perimetry is
not able to identify the area and quantify the stability of
the fixation, particularly in partially sighted subjects. The
fundamental issue is the impossibility of controlling ocular
movements and displaying ocular fundus in real time during
the test.
Conversely, microperimetry (MP) is a new-generation
morphofunctional technique that does not show this limit,
allowing performing an electronic view field contemporarily
to the display of stimulated dots within patient’s ocular
fundus.
The sensitivity map is generated by observing in a con-
tinuative way the ocular fundus and projecting light stimuli
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Figure 1: (a) Infrared image of the ocular fundi. (b) Computerized perimetry. (c) Digital image of the ocular fundi. (d) Microperimetric
image.
in retinal areas selected by the operator. In this way, it
becomes possible to correlate specific dots within the ocular
fundi with the eventual alterations of retinal sensitivity and
thus to associate objectively the morphologic retinal changes
ophthalmoscopically observed and the subsequent functional
alterations (Figure 1).
Currently, the use of microperimetry to study glaucoma
progression consists in the analysis of peripapillary retinal
sensitivity through the use of light stimuli projected radially
to the optic disc (12 meridians) (Figure 2).
In this way, microperimetry could be able to detect and
monitor the damage of RNFL in subjects affected by glau-
coma.
The possibility of evaluating contemporarily both reti-
nal sensitivity and the direct observation of ocular fundus
allows limiting microperimetric analysis to selected areas
that would show defects localized within the retinal nerve
fiber layer (RNFL), leading to the identification of func-
tionally abnormal areas and allowing an eventual follow-
up evaluation. In addition, microperimetry is able to detect
and monitor precocious and specific RNFL impairment
and, when it is conspicuous, could lead to a progressive
enlargement of the physiological optic papilla excavation and
visual field impairment. Therefore, the early evaluation of
Figure 2: Analysis of the peripapillary retinal sensitivity by Mp-1
projecting light stimuli in radial manner to the optic papillae (12
meridians).
morphofunctional alterations at this level is crucial in the
diagnosis and prevention of the glaucomatous disease.
The aim of the study was the application of microperime-
try, correlating it with Humphrey perimetry 30-2, in patients






















































Figure 3: Quadrant correspondence between Mp-1 and Humphrey.
Figure 4: Example of the perimetric abnormalities analyzed by
microperimetric test with both Mp-1 (interpolated map) and
Humphrey 30-2 perimetry.
with primary open-angle glaucoma with perimetric defects
“localized” at the papillary level in order to get an assessment
of the accuracy of the results obtained by Mp, which could
then be used routinely for early diagnosis of the disease
and close follow-up in the prevention of damage caused by
glaucoma (Figures 3 and 4).
2. Materials and Methods
In this study, 40 eyes from 25 patients (10 females and 15
males) affected by chronic open-angle glaucoma or focal
papillary perimetric abnormalities, comparing them with
Humphrey 30-2 perimetry threshold test, have been included.
The exclusion criteria were represented by (i) the opacity of
dioptric lens, (ii) previous ocular surgery (cataract, glaucoma,
and retinal detachment), and the presence of type II diabetes,
blood hypertension, and other systemic disorders.
Each patient underwent an ophthalmologic visit includ-
ing Best Corrected Visual Acuity (BCVA), anterior segment
examination, fundus examinations (evaluation of glaucoma-
tous optic disc damage compared to the value of cup/disc
ratio), and gonioscopy to classify anterior chamber angles
according to Shaffer system. Furthermore, the same operator
performed a tonometric curve during the same day to each
patient.
Each patient was tested with microperimetry Nidek Mp-
1 (NAVIS software version 1.7.2; Nidek Technologies) applied
to conventional static perimetric analysis.
The hardware is composed of an IR fundus camera (IR
light with filtered halogen lamp, 768 × 576 pixel resolution)
allowing both a dynamic visualization and a real-time retinal
examination for a 45∘ exam angle.
The fundus camera is equipped with a lens system for
correcting patient’s refractive defect in a range of −12.5/+16
diopters; because of this system the invasiveness and patient’s
discomfort are reduced during the exam, and the accuracy
functional evaluation and focus of the retinal image are
improved.
In addition to that, this tool is equipped with a color
fundus camera (CCD camera progressive scan, 780×580 pixel
resolution, including Xenon flash) allowing the acquisition
of high-quality digital retinoic picture where it is possible
to select retinal spots (e.g., superficial retinal vessels or
optic disc) and a system of eye-tracking which is able to
compensate instinctive ocular movements occurring during
test performance allowing testing the fixation throughout the
functional test.
All the tests were performed in the same room with
low luminance, by the same skilled operator, minimizing
potential biases.
Additional parameters selected for microperimetry
included 15 × 15∘ field, 1.27 cd/m2-white background, mag-
nitude of the stimulus Goldmann III white-100ms, initial
attenuation of 20 dB, threshold strategy (4-2-1), 77 tested
dots, and single cross fixation sight 1∘ (Table 1).
Moreover, the computerized campimetric evaluation by
Humphrey 30-2 was performed using the following param-
eters: 15 × 15∘ field, 1.27 cd/m2-white background, magni-
tude of the stimulus Goldmann III white-100ms, threshold
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Table 1: Parameters used with bothMp-1 and Humphrey perimetry
methods.
Parameter Humphrey Mp-1
Field 15∘ × 15∘ 15∘ × 15∘
Background 31.3-white 1.27 cd/m2-white
Stimuli Goldmann III Goldmann III
White-100ms White-100ms
Strategy SITA-Standard 4-2-1
Fixation sight Central Single cross 1∘
Tested dots 76 77
strategy SITA-Standard, 25 tested dots, and single cross cen-
tral fixation sight 1∘ (Table 1). For each campimetric test (H)
an inverse subdivision in quadrants was obtained compared
to the microperimetric exam (M).
Mean values of dB sensitivity in each tested dot obtained
with the microperimetric test were correlated with the cor-
responding values obtained by conventional static perimetric
analysis.
SPSS programme has been used for statistical analysis.
Data were analyzed using both Pearson’s correlation and
Bland-Altman analysis. Data passing 𝑝 < 0.01 cut-off were
considered statistically significant.
3. Results
Mean age of study populationwas 56.96 years± 9.02 (M± SD;
age ranging from 37 to 70 years). All patients showed BCVA
values >8/10 (Snellen optotype); slit-lamp exam of anterior
chamber was normal and cup/disc ratio was <0.3 tested by
direct ophthalmoscopy.
Gonioscopy performed on all subjects detected a 4∘ angle
according to Shaffer.
IOP after tonometric curves resulted in no change during
combined therapy with more than one antiglaucoma drug,
with mean value of 14mmHg ± 3mmHg.
Interpolated results showed mean value of sensitivity for
each tested dot with Mp-1 of 11.98 dB ± SD 4.31. They may be
correlated with mean total values or with mean values of the
corresponding quadrant tested by Humphrey 30-2 perimetry
(17.95 dB with SD 4.32), with correlation coefficient of 0.556
(Table 2(a)).
The comparison for corresponding quadrants with regard
to the defects observed resulted to be statistically significant
for parapapillary sectors, with values of H3-M3 (H3-11.06 dB;
M3-13.50 dB) and H4-M4 (H4-18.17 dB; M4-11.77 dB), with
0.762 and 0.456 (Table 2(b)), respectively.
Data were obtained by Bland-Altman analysis. As shown
in Tables 3 (Figure 5), 4 (Figure 6), 5 (Figure 7), and 6
(Figure 8), there was an average value of 7.35 (SD: 6.17) for
S-T/I-N (H1-M1) quadrants, an average value of 12.24 (SD:
5.245) for I-T/S-N (H2-M2) quadrants, an average value
of −2.802 (SD: 3.836) for I-N/S-T (H3-M3) quadrants, and
an average value of 5.822 (SD: 13.48) for S-N/I-T (H4-M4)
quadrants.
Table 2: (a) Mean sensitivity (dB) and standard deviation (SD)
for each quadrant; (b) Pearson’s correlation between corresponding







H1 18.60 5.15 0.297
M1 11.24 5.13
H2 23.32 4.03 0.295
M2 10.68 3.20
H3 11.06 3.25 0.762
M3 13.50 4.23
H4 18.17 10.84 0.456
M4 11.77 5.87
H tot 17.95 4.32 0.556
M tot 11.98 4.31







































∗∗Correlation is significant at the 0.01 level (2–4 tailed).
4. Discussion
In the last years, microperimetry has beenwidely used in case
of macular disorders, evaluating retinal sensitivity of central
area [2, 3]. Its application in glaucomatous optic neuropathy
is recent with different modalities for various analyses. The
acquisition of a new-generation microperimetric method is
better than previous tests that lacked standardization of the
procedure; it was impossible for them to perform follow-
up tests for the same retinal spot, and they lacked colored
visualization of the fundus. This technical improvement led
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Table 3: Quarter S-N/I-T Bland-Altman analysis (see Figure 5).
Method 1 Method 2 Bland-Altman analysis
Difference Average
12.4 15.3 −2.9 13.85
26.5 13.6 12.9 20.05
27.7 16.2 11.5 21.95
15.5 4.7 10.8 10.1
22.6 15.3 7.3 18.95
24.1 5.6 18.5 14.85
14.1 2.8 11.3 8.45
20.5 16.1 4.4 18.3
14.3 2.7 11.6 8.5
12.4 14.6 −2.2 13.5
17.5 15.3 2.2 16.4
14.5 10.8 3.7 12.65
17.4 14.9 2.5 16.15
21.5 12.8 8.7 17.15
12.5 15 −2.5 13.75
27 13 14 20
28 16 12 22
16 5 11 10.5
22 15 7 18.5
24 5 19 14.5
14 3 11 8.5
20 15.8 4.2 17.9
14.5 2.5 12 8.5
12 14 −2 13
17 15 2 16
14.7 10.6 4.1 12.65
17 14.5 2.5 15.75
21 13 8 17
12 15.7 −3.7 13.85
26 13.9 12.1 19.95
27.4 15.8 11.6 21.6
15 4.5 10.5 9.75
23 14.7 8.3 18.85
24.5 4.6 19.9 14.55
14.5 3.2 11.3 8.85
21 16.4 4.6 18.7
14 2.3 11.7 8.15
13 15 −2 14
18 14.8 3.2 16.4
14.3 10.4 3.9 12.35
Average 7.35
SD 6.171
to an increased interest for its application on glaucoma.
Because of these advantages Mp-1 has been used to evaluate
functional and morphological alterations at molecular level
and the fixation in glaucoma-affected patients [4, 5]. To our
knowledge, no previous studies evaluated the correlation
Table 4: Quarter I-T/S-N Bland-Altman analysis (see Figure 6).
Method 1 Method 2 Bland-Altman analysis
Difference Average
25.4 10.61 14.79 18
28 10.4 17.6 19.2
25.8 12.7 13.1 19.25
20.1 6.5 13.6 13.3
18.9 17.7 1.2 18.3
20.3 4.7 15.6 12.5
25.9 9.7 16.2 17.8
23.5 13.1 10.4 18.3
27.6 9.8 17.8 18.7
15 10.7 4.3 12.85
27.5 14.2 13.3 20.85
26 9.4 16.6 17.7
25 14.2 10.8 19.6
27.5 11.2 16.3 19.35
25.5 10 15.5 17.75
20.4 10.2 10.2 15.3
19.2 13 6.2 16.1
20 6 14 13
23 17.5 5.5 20.25
26.2 5 21.2 15.6
23 10 13 16.5
25.2 13 12.2 19.1
28 10.1 17.9 19.05
14.7 10.4 4.3 12.55
26 14 12 20
28.5 9 19.5 18.75
26.1 11 15.1 18.55
19.8 10.8 9 15.3
18.6 12.5 6.1 15.55
19.7 7 12.7 13.35
22.7 18 4.7 20.35
25.6 4.5 21.1 15.05
24 9.5 14.5 16.75
25.6 11 14.6 18.3
27.5 14.5 13 21
15.2 9.7 5.5 12.45
15.5 10.3 5.2 12.9
27.2 9.6 17.6 18.4
25.2 10.6 14.6 17.9
26 23.2 2.8 24.6
Average 12.24
SD 5.245
between Mp-1 and Humphrey 30-2 perimetry outcomes for
the evaluation of papillary-derived view field defects. Up
to now, Humphrey 30-2 perimetry is considered the gold
standard for the diagnosis and follow-up of glaucomatous
diseases. The analyses of our outcomes led to considering
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Table 5: Quarter I-N/S-T Bland-Altman analysis (see Figure 7).
Method 1 Method 2 Bland-Altman analysis
Difference Average
10.6 15.3 −4.7 12.95
10.4 13.6 −3.2 12
12.7 16.2 −3.5 14.45
6.5 5.6 0.9 6.05
17.7 16.3 1.4 17
4.7 4.4 0.3 4.55
9.7 10.9 −1.2 10.3
13.1 18.3 −5.2 15.7
9.8 11 −1.2 10.4
13.1 15.4 −2.3 14.25
9.8 15.7 −5.9 12.75
10.7 17.8 −7.1 14.25
14.2 15.7 −1.5 14.95
9.4 11.6 −2.2 10.5
14.2 15 −0.8 14.6
11.2 13.2 −2 12.2
10 16 −6 13
10.2 5.2 5 7.7
13 16 −3 14.5
6 4 2 5
17.5 11 6.5 14.25
5 18.6 −13.6 11.8
10 11.5 −1.5 10.75
13 15 −2 14
10.1 15.2 −5.1 12.65
10.4 18 −7.6 14.2
14 15.7 −1.7 14.85
9 15.5 −6.5 12.25
11 15.6 −4.6 13.3
10.8 13.6 −2.8 12.2
12.5 16.4 −3.9 14.45
7 5.8 1.2 6.4
18 16 2 17
5 10.7 −5.7 7.85
10 18 −8 14
12.9 10.5 2.4 11.7
10.3 16 −5.7 13.15
11 15.9 −4.9 13.45
14.5 17.5 −3 16
9.6 17 −7.4 13.3
Average −2.802
SD 3.836
that conventional perimetry using Mp-1 microperimeter in
patients affected by chronic glaucoma is accurate because of
the statistically significant correlation with Humphrey 30-2
perimetry.
This correlation is even more marked for the campimet-
ric inferonasal quadrant (microperimetric superotemporal
Table 6: Quarter S-N/I-T Bland-Altman analysis (see Figure 8).
Method 1 Method 2 Bland-Altman analysis
Difference Average
0.3 15.3 −15 7.8
27 13.6 13.4 20.3
0.7 16.2 −15.5 8.45
28 4.4 23.6 16.2
14.3 16 −1.7 15.15
24.2 3.6 20.6 13.9
19.6 2.3 17.3 10.95
6.2 16.6 −10.4 11.4
26.1 2.2 23.9 14.15
6.3 15 −8.7 10.65
0.3 16.9 −16.6 8.6
29.7 13.4 16.3 21.55
24 17.1 6.9 20.55
29.6 12.8 16.8 21.2
18.5 15 3.5 16.75
0.4 13 −12.6 6.7
28 16 12 22
27.5 4 23.5 15.75
14 15.8 −1.8 14.9
24 3.3 20.7 13.65
19 2 17 10.5
6 16 −10 11
26 2 24 14
6 14.8 −8.8 10.4
26 16.7 9.3 21.35
6 13.3 −7.3 9.65
0.2 17.5 −17.3 8.85
30 15.7 14.3 22.85
23.9 14 9.9 18.95
29.4 16.5 12.9 22.95
0.3 5 −4.7 2.65
27 16.2 10.8 21.6
28.5 3.8 24.7 16.15
14.6 2.5 12.1 8.55
24.5 17 7.5 20.75
20 2.4 17.6 11.2
6.5 15.3 −8.8 10.9
25.8 17.2 8.6 21.5
5.7 13.7 −8 9.7
29.5 16.6 12.9 23.05
Average 5.822
SD 13.48
quadrant) and superonasal quadrant (microperimetric infer-
otemporal quadrant), well known to be primarily affected by
loss of ganglion cells.
The relevance of obtained results is related to the accuracy
of this new analysis in evaluating functional glaucoma dam-
age. Furthermore, it is a morphofunctional procedure that
is able to evaluate the sensitivity threshold with topographic

























accuracy, as it is possible to establish with accuracy the
retinic dots that are stimulated by a system of direct retinal
visualization.
This aspect is relevant because Mp-1 would result as
a follow-up test, highly useful to monitor glaucoma. The
traditional electronic Humphrey 30-2 perimetry consists
in identifying stimulated retinic areas in their geometric
position compared to the patient’s fixation point.This type of
test does not provide any correlation between ocular fundus
test and the retinal sensitivity in a specific point, as it is not
possible to have a direct observation of ocular fundus and to
identify where the light stimuli will be projected.
Topographic visualization of the perimetric defect
detected by microperimetry would allow retesting zones
with reduced sensitivity (localized abnormalities) which are
topographically visualized and displayable on the ocular
fundi, avoiding worsening of the functional defect by a better
modulation of the antiglaucoma therapy and allowing better
monitoring of the pathologic functional damage.
Therefore, we may conclude that Mp-1 microperimetry

























maps easy to read and could be used for glaucomatous
patient’s follow-up correlated with methods that are widely
standardized in the glaucoma semeiotic.
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